Clinical Trial Update: IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 study evaluating an IDO peptide vaccination in patients with stage III-IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• IDO peptide vaccination (IDO peptide vaccine)

Snippet

Sponsor: Inge Marie Svane | Conditions: NSCLC, Lung Cancer | Phase 1 | Status: COMPLETED